|
US4018653A
(en)
|
1971-10-29 |
1977-04-19 |
U.S. Packaging Corporation |
Instrument for the detection of Neisseria gonorrhoeae without culture
|
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
|
US4424279A
(en)
|
1982-08-12 |
1984-01-03 |
Quidel |
Rapid plunger immunoassay method and apparatus
|
|
ATE132269T1
(de)
*
|
1990-11-30 |
1996-01-15 |
Monoclonetics Int |
Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
|
|
ATE335072T1
(de)
|
1993-05-28 |
2006-08-15 |
Scripps Research Inst |
Methoden für inhibition der cd14-abhängigen zellaktivierung
|
|
CA2319828A1
(en)
|
1998-01-29 |
1999-08-05 |
Miller, Samuel |
High density arrays for proteome analysis and methods and compositions therefor
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
EP1354037A2
(en)
|
2000-04-17 |
2003-10-22 |
TransTech Pharma, Inc. |
Protein expression system arrays and use in biological screening
|
|
GB0022978D0
(en)
|
2000-09-19 |
2000-11-01 |
Oxford Glycosciences Uk Ltd |
Detection of peptides
|
|
WO2002039120A1
(en)
|
2000-11-09 |
2002-05-16 |
Bionova Pharmaceutials, Inc. |
A method for identifying the proteome of cells using an antibody library microarray
|
|
JPWO2002042333A1
(ja)
|
2000-11-22 |
2004-03-25 |
持田製薬株式会社 |
Ｃｄ１４／ｔｌｒ結合阻害作用を有する抗ｃｄ１４モノクローナル抗体
|
|
WO2002059601A1
(en)
|
2001-01-23 |
2002-08-01 |
President And Fellows Of Harvard College |
Nucleic-acid programmable protein arrays
|
|
US20050003360A1
(en)
|
2001-11-13 |
2005-01-06 |
Ruo-Pang Huang |
Array systems and methods
|
|
US7030126B2
(en)
*
|
2001-11-16 |
2006-04-18 |
Als Therapy Development Foundation, Inc. |
Use of polyamine analogs for amyotrophic lateral sclerosis
|
|
ES2319634T3
(es)
|
2002-03-11 |
2009-05-11 |
Caprotec Bioanalytics Gmbh |
Compuestos y metodos para analizar el proteoma.
|
|
WO2005020784A2
(en)
*
|
2003-05-23 |
2005-03-10 |
Mount Sinai School Of Medicine Of New York University |
Surrogate cell gene expression signatures for evaluating the physical state of a subject
|
|
WO2005108429A1
(ja)
*
|
2004-05-11 |
2005-11-17 |
Mochida Pharmaceutical Co., Ltd. |
新規可溶性ｃｄ１４抗原
|
|
HUE043684T2
(hu)
|
2009-03-11 |
2019-09-30 |
Augurex Life Sciences Corp |
Arthritikus állapotok jellemzésére szolgáló készítmények és eljárások
|
|
BR112012002333A2
(pt)
*
|
2009-08-06 |
2017-07-18 |
Neuraltus Pharmaceuticals Inc |
método de reduzir os efeitos colaterais e método de potencializar o efeito de um imunomodulador administrado a um sujeito que dele necessita; métodos para tratar doença associada com excesso de ativação de monócitos para macrófagos ativados, diabetes tipo ii ou complicações relacionadas, doença associada com a migração de monócitos ou macrófagos ativados, doença associada a excesso de produção de scd14 e/ou scd163 por macrófagos ativados; composto de cloreto de sódio; composição farmacêutica; método para diagnosticar uma doença relacionada com macrófagos em um sujeito; e método para determinar a eficácia do tratamento com um agente oxidante para uma doença relacionada a macrófagos em um sujeito.
|
|
US8465727B2
(en)
|
2009-10-06 |
2013-06-18 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Biomarkers for the diagnosis of ALS
|
|
EP2501720A2
(en)
*
|
2009-11-18 |
2012-09-26 |
Lascco SA |
Ifn inhibitors in the treatment of motoneuron diseases
|
|
CA2792471A1
(en)
|
2010-03-10 |
2011-09-15 |
Yeda Research And Development Co. Ltd |
Cellular blood markers for early diagnosis of als and for als progression
|
|
WO2012004276A2
(en)
*
|
2010-07-06 |
2012-01-12 |
Fondazione Telethon |
Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits
|
|
KR20140057316A
(ko)
*
|
2011-08-12 |
2014-05-12 |
미쓰비시 가가쿠 메디엔스 가부시키가이샤 |
수술 후 감염증을 진단하는 방법
|
|
CN104011210B
(zh)
*
|
2011-10-11 |
2018-05-01 |
布里格姆及妇女医院股份有限公司 |
神经退行性病症中的microRNA
|
|
US20150346217A1
(en)
*
|
2012-12-28 |
2015-12-03 |
Lsi Medience Corporation |
USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS
|
|
JP2017518265A
(ja)
*
|
2014-05-16 |
2017-07-06 |
ニューラルタス ファーマシューティカルズ，インク． |
マクロファージ関連疾患の処置のための方法と組成物
|
|
CN107003320B
(zh)
*
|
2014-11-25 |
2021-08-17 |
豪夫迈·罗氏有限公司 |
慢性肾脏疾病的快速进展的生物标志物
|
|
EP3277312A2
(en)
*
|
2015-04-02 |
2018-02-07 |
The Methodist Hospital System |
Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity
|
|
EP3391057B1
(en)
*
|
2015-12-16 |
2020-04-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
|
|
IL270097B2
(en)
|
2017-04-21 |
2024-05-01 |
Implicit Bioscience Ltd |
Antibodies antagonistic to CD14 for the treatment of neurodegenerative diseases
|